Cancer Clinical Trial
Collection of Malignant Ascites, Pleural Fluid, and Blood From Patients With Solid Tumors
|Source||National Institutes of Health Clinical Center (CC)|
|Contact||Irene Ekwede, R.N.|
|Start date||May 22, 2017|
|Completion date||January 4, 2028|
Researchers want to study fluids and blood of people with cancer. The fluids are from the abdomen and around the lungs. Studying these might help researchers learn about the biology of cancer. This may lead to better ways to treat cancer.
To study the biology of cancer.
Adults 18 and older with malignant solid tumors.
Participants will be screened with medical history, blood tests, and confirmation of diagnosis.
Participants will have samples taken at regularly scheduled procedures. Fluids from the abdomen and/or lungs will be taken as part of the procedures. Blood will be taken separately.
Participants may be asked to give more samples at future procedures.
-Malignant ascites or pleural effusions are often seen in patients with solid tumor
-Malignant ascites is proinflammatory with many cytokines present and acts to promote
tumor cell growth.
-The cellular composition of malignant ascites consists of lymphocytes, macrophages and
-Serum monocytes and lymphocytes play a role in the native host anti-tumor immune
-A paracentesis or thoracentesis is often done for symptomatic relief from the malignant
-To obtain blood samples and ascites and pleural effusion samples from patients with solid
tumor malignancies, with the intent of performing translational studies related to cancer.
- Patients greater than or equal to 18 years of age.
- Diagnosis of malignant solid tumor.
- Patients must be able and willing to provide informed consent.
-We will collect approximately 200cc-5L ascites from patients that are undergoing a
therapeutic paracentesis or thoracentesis. No thoracentesis or paracentesis will be
performed solely for research purposes.
-The fluid will be collected during the medical procedure and may be collected at more
than one time point.
-We will also collect 30ml of peripheral blood. This will be from patients who are being
seen in follow up, consultation, or presenting for enrollment on a clinical trial.
|Recruiting||NCT01285037 - A Study of LY2801653 in Advanced Cancer||Phase 1|
|Active, not recruiting||NCT00680992 - Study of Denosumab in Subjects With Giant Cell Tumor of Bone||Phase 2|
|Completed||NCT00340522 - Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development||N/A|
|Terminated||NCT01441115 - ECI301 and Radiation for Advanced or Metastatic Cancer||Phase 1|
|Completed||NCT01077414 - Phenomenological Study of Psycho-Socio-Spiritual Healing in the Context of Chronic or Life-Threatening Illness||N/A|
|Active, not recruiting||NCT00587886 - Estrogen, Diet, Genetics and Endometrial Cancer||N/A|
|Enrolling by invitation||NCT02565004 - Clinical and Laboratory Analysis of Familial Cancer||N/A|
|Recruiting||NCT02921919 - Open-Label Extension and Safety Study of Talazoparib||Phase 2|
|Recruiting||NCT02869802 - Prospectively Defining Metastatic Pancreatic Ductal Adenocarcinoma Subtypes by Comprehensive Genomic Analysis||N/A|
|Recruiting||NCT02839889 - Tolerability, Safety, and Feasibility of Naloxegol in Patients With Cancer and OIC (Opioid Induced Constipation)||Phase 4|
|Recruiting||NCT02891993 - Pilot Study of a Symptom Monitoring Intervention for Hospitalized Patients With Cancer||N/A|
|Not yet recruiting||NCT02883699 - Individually Tailored Training Prescriptions in Cancer Patients: The TOP Study||N/A|
|Recruiting||NCT02758639 - Wonders & Worries: A Clinical Trial of a Psychosocial Intervention for Children Who Have a Parent With Cancer||N/A|
|Recruiting||NCT02552953 - A Pharmacologic Study of CYC065, a Cyclin Dependent Kinase Inhibitor, in Patients With Advanced Cancers||Phase 1|
|Recruiting||NCT02528357 - GSK3174998 Alone or With Pembrolizumab in Subjects With Advanced Solid Tumors (ENGAGE-1)||Phase 1|
|Recruiting||NCT02662621 - Pilot Study With the Aim to Quantify a Stress Protein in the Blood and in the Urine for the Monitoring and Early Diagnosis of Malignant Solid Tumors||N/A|
|Recruiting||NCT02502396 - Rivaroxaban Utilization for Treatment and Prevention of Thromboembolism in Cancer Patients: Experience at a Comprehensive Cancer Center||N/A|
|Recruiting||NCT02550925 - Acceptance and Commitment Therapy (ACT) for Anxious Cancer Survivors||N/A|
|Recruiting||NCT02866851 - Feasibility Study of Monitoring by Web-application on Cytopenia Related to Chemotherapy||N/A|
|Recruiting||NCT02483247 - A Study of BBI503 in Combination With Selected Anti-Cancer Therapeutics in Adult Patients With Advanced Cancer||Phase 1/Phase 2|